Revefenacin
1 NDC across 1 manufacturer|0 Generic,1 Brand
Revefenacin is used to treat chronic obstructive pulmonary disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 9, 2018. In 2024, Medicare Part D spent $7 million on Revefenacin across 5,673 claims for 1,636 beneficiaries.
Revefenacin is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $17.43 to $17.43 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$17.43 – $17.43
per ML
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Viatris Specialty LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Anticholinergic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing REVEFENACIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
YUPELRI 175 MCG/3 ML SOLUTION | $17.4271 per ML | +0.04% |
Frequently Asked Questions
What is Revefenacin used to treat?
Revefenacin is used to treat chronic obstructive pulmonary disease, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Revefenacin?
In 2024, Medicare Part D spent $7 million on Revefenacin across 5,673 claims for 1,636 beneficiaries.
How many Revefenacin products are on the market?
The Revefenacin drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Revefenacin?
NADAC reference prices for Revefenacin range from $17.4271 to $17.4271 per ML.
Which manufacturers make Revefenacin?
1 manufacturer lists Revefenacin in NADAC. Ranked by number of NDCs, the largest are Viatris Specialty LLC (1).
How has the price of Revefenacin changed recently?
Over the past 7 days, 1 Revefenacin NDC rose and 0 fell, with a market-wide average change of +0.0%.